搜索临床试验以:SU011248; Capecitabine
总计1983个结果
-
Asan Medical CenterSeoul National University Bundang Hospital; Severance Hospital; Hallym University Medical Center; Inha University Hospital招聘中
-
Peking UniversityXiansheng Pharmaceutical Company完全的
-
South Eastern European Research Oncology GroupRoche Pharma AG未知
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Sun Yat-sen UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
AVEO Pharmaceuticals, Inc.完全的
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline完全的
-
National Cancer Center, KoreaKorean Cancer Study Group未知
-
Croatian Cooperative Group for Clinical Research...Roche Pharma AG未知
-
University Health Network, TorontoNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
Peking University Cancer Hospital & InstitutePeking University People's Hospital; Peking Union Medical College Hospital招聘中
-
Jiangsu HengRui Medicine Co., Ltd.未知
-
Dutch Colorectal Cancer GroupSanofi; Roche Pharma AG终止
-
Norwegian Breast Cancer Group完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Indiana University School of MedicineAventis Pharmaceuticals完全的
-
Roswell Park Cancer Institute完全的
-
Fudan University暂停
-
Cancer Research NetworkHoffmann-La Roche完全的